Wesfarmers (ASX:WES) is well-positioned to take share in the current market backdrop, further supported by scale and digital, Jarden said in a note on Monday.

It also expects positive earnings-per-share consensus revisions, underpinned by updated near-term lithium price forecasts.

Wesfarmers is executing well and has a clear plan within the existing corporate envelope. In the medium term, there is a material opportunity for it to become the leading customer-facing business in Australia across health, consumables, goods, and energy, although this will require time and money, per the note.

The investment firm retained its neutral rating on Wesfarmers and raised the price target to AU$75.30 per share from AU$74.50 per share.